THE DIFFERENCE OF
ONE IN A MILLION

Thank you to every nurse, on every shift in every moment of care.

To say BD values nurses is an understatement. We know that, without you, modern medicine makes fewer miracles. Without your leadership, example and influence on safety, patients face incalculable risks. And without your reassuring presence, few receive that vital dose of human kindness that helps healing begin. You are the difference makers at the front lines of clinical excellence and innovation. This is why we do our best to provide you safer, smarter and simpler technologies and support for sound and effective medication administration. Hats off to you for National Nurse’s Week – and for the other 51 weeks of the year when you give us what no one else does better. Discover the gratitude of one company. Discover the new BD.


Nursing Conferences

Let's connect at these upcoming industry events:

Oncology Nursing Society
May 17-20, 2018
Washington, DC

Infusion Nurses Society
May 19-22, 2018
Cleveland, OH

ANA Innovation Awards Powered by BDTM

As the largest group of healthcare providers in the US Workforce, 3.8 million Registered Nurses care for patients in our communities, hospitals and homes, every day. Nurses are creative innovators, dedicated to discovering ways to improve outcomes and spend more time with their patients on care activities that matter most.

To highlight and encourage this spirit of nursing innovation, the American Nurses Association (ANA) has partnered with BD (Becton, Dickinson and Company) to launch the ANA Innovation Awards™ powered by BD. The awards will be presented to a nurse and a nurse-led team who best exemplify nurse-led innovation in patient safety and/or outcomes, by way of a product, program, project or practice.

The ANA Innovation Awards will include a $25,000 award to an individual nurse and a $50,000 award to a nurse-led team.

This new program, announced at the ANA Quality and Innovation Conference, is made possible through the generosity of a $500,000 contribution over 3 years by BD. BD honors the role of nurses as leaders in healthcare delivery and applauds nursing efforts to improve patient-centric care delivery models and practice.

There will be more details to come from ANA and BD on this new awards program. The application will open in June.

Learn more

Join us for a webinar series on managing opioids in the acute care setting

Abuse of prescription opioids has grown dramatically over the last 15 years,1 becoming one of the most serious public health problems in the United States. Opioids are overprescribed, resulting in nonmedical consumption and abuse, and often leading to the use of illicit forms of opiates such as heroin. The prescription opioid crisis costs our country an estimated $55 billion in health and social costs every year2 with devastating consequences to communities and families across the country. Acute care providers are on the front lines of this public health epidemic every day as a result of drug diversion, transitions of care from the hospital and the toll on emergency departments.

In this series, we will discuss the advantages of a collaborative approach to managing controlled substances, and learn about the value of a culture of safety as part of a health system’s drug diversion deterrence plan.

The role of the medication safety officer in addressing institutional drug diversion

The Medication Safety Officer is a new and important role in health systems. Learn how creating a culture of safety can help to deter diversion of controlled substances.
When: May 18, 9 a.m. (PST)
Speaker: Christina Michalek, BSc Pharm, RPh, FASHP, Medication Safety Specialist, ISMP
Objectives:

•Explain the role of the medication safety clinician
•Evaluate opportunities to facilitate improvements in the management of controlled substances
•Identify gaps in structure elements that may contribute to controlled substance diversion
•Apply a pearl or idea learned today to improve the work that you do

Register now

Decreasing the risk of drug diversion: a nursing viewpoint, a collaborative approach

Drug diversion is not a nursing problem. Drug diversion is not a pharmacy problem. Drug diversion is a systemic problem and the risks are better managed with a collaborative approach.
When: July 20, 9 a.m. (PST)
Speaker: Kim New, JD, BSN, RN, Executive Director, International Health Facility Diversion Association
Objectives:

• Learn how to collaborate with colleagues across departments as a task force to combat drug diversion before it happens at your facility
• Develop a system to monitor the effectiveness of your drug diversion deterrent efforts
• Describe the elements of a culture of compliance
• Summarize best practices for surveillance for nurses and pharmacists

Register now

BD habitant morbiTM

Pellentesque habitant morbi tristique senectus et netus et malesuada fames ac turpis egestas vestibulum tortor quam.

More product details

Ibus exped et ape

Pellentesque habitant morbi tristique senectus et netus et malesuada fames ac turpis egestas vestibulum tortor quam.

Ibus exped et ape

Pellentesque habitant morbi tristique senectus et netus et malesuada fames ac turpis egestas vestibulum tortor quam.

Ibus exped et ape

Pellentesque habitant morbi tristique senectus et netus et malesuada fames ac turpis egestas vestibulum tortor quam.

Ibus exped et ape

Pellentesque habitant morbi tristique senectus et netus et malesuada fames ac turpis egestas vestibulum tortor quam.

Ibus exped et ape

Pellentesque habitant morbi tristique senectus et netus et malesuada fames ac turpis egestas vestibulum tortor quam.


Thank you for your commitment to patient safety.

Play

Discover the difference

Thank you for your interest in BD solutions. We look forward to starting the conversation. Learn how the comprehensive BD medication management ecosystem addresses end-to-end infusion safety and efficiency @ bd.com/FewerMedErrors
References

1 Rudd RA, Noah A, Zibbell JE, Gladden RM. Increases in Drug and Opioid Overdose Deaths — United States, 2000–2014. CDC MMWR. 2016; 64(50);1378-82. 2 Birnbaum HG, White AG, Schiller M, Waldman T, Cleveland JM, Roland CL. Societal costs of prescription opioid abuse, dependence, and misuse in the United States. Pain Med. 2011;12(4):657-67.

Micro Loop and MicroLab eTraining